| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |